← Back to headlines
Plus Therapeutics Reports Q1 GAAP EPS Miss and Revenue Beat
Plus Therapeutics announced its GAAP EPS of -$1.05, missing estimates by $0.15, while its revenue of $1.03 million surpassed expectations by $0.06 million.
15 May, 21:02 — 15 May, 21:02
Sources
Showing 1 of 1 sources
